High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine

Pediatric Blood and Cancer

Volumn 60, Issue 7, 2013, Pages 1154-1160

  Johannsen, Katrine Helle ^a   Handrup, Mette Møller ^a   Lausen, Birgitte ^b   Schrøder, Henrik ^a   Hasle, Henrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acute myeloid leukaemia; Bacteraemia; Cytarabine; Infections; Paediatric; Viridans group streptococci

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CIPROFLOXACIN; COTRIMOXAZOLE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; GENTAMICIN; IDARUBICIN; MEROPENEM; METHOTREXATE; METRONIDAZOLE; MITOXANTRONE; PIPERACILLIN PLUS TAZOBACTAM; TIOGUANINE; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CANCER CHEMOTHERAPY; CAUSE OF DEATH; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; DRUG DOSAGE FORM COMPARISON; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; FUNGAL STRAIN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION RISK; LOW DRUG DOSE; MALE; NEUTROPENIA; NONHUMAN; PENICILLIN RESISTANCE; PNEUMOCYSTIS PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; STREPTOCOCCAL BACTEREMIA; SYSTEMIC MYCOSIS;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CYTARABINE; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 84878219835     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24448     Document Type: Article

References (27)

1. Lie SO, Abrahamsson J, Clausen N, et al. Long-term results in children with aml: NOPHO-AML study group-report of three consecutive trials. Leukemia 2005;19:2090-2100.
2. Sung L, Lange BJ, Gerbing RB, et al. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood 2007;110:3532-3539.
3. Lehrnbecher T, Varwig D, Kaiser J, et al. Infectious complications in pediatric acute myeloid leukemia: Analysis of the prospective multi-institutional clinical trial aml-bfm 93. Leukemia 2004;18:72-77.
4. Molgaard-Hansen L, Mottonen M, Glosli H, et al. Early and treatment-related deaths in childhood acute myeloid leukaemia in the nordic countries: 1984-2003. Br J Haematol 2010;151:447-459.
5. Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: Epidemiology, microbiology, and risk stratification. Clin Infect Dis 2005;40:S240-S245.
6. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004;39:S25-S31.
7. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999;29:490-494.
8. Sung L, Buxton A, Gamis A, et al. Life-threatening and fatal infections in children with acute myeloid leukemia: A report from the children's oncology group. J Pediatr Hematol Oncol 2012;34:e30-e35.
9. Gamis AS, Howells WB, DeSwarte-Wallace J, et al. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: A report from the children's cancer group study CCG-289. J Clin Oncol 2000;18:1845-1855.
10. Bruckner LB, Korones DN, Karnauchow T, et al. High incidence of penicillin resistance among alpha-hemolytic streptococci isolated from the blood of children with cancer. J Pediatr 2002;140:20-26.
11. Bruckner L, Gigliotti F. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin Pediatr Infect Dis 2006;17:153-160.
12. Weisman SJ, Scoopo FJ, Johnson GM, et al. Septicemia in pediatric oncology patients: The significance of viridans streptococcal infections. J Clin Oncol 1990;8:453-459.
13. Rossetti F, Cesaro S, Putti MC, et al. High-dose cytosine arabinoside and viridans streptococcus sepsis in children with leukemia. Pediatr Hematol Oncol 1995;12:387-392.
14. Engelhard D, Elishoov H, Or R, et al. Cytosine arabinoside as a major risk factor for streptococcus viridans septicemia following bone marrow transplantation: A 5-year prospective study. Bone Marrow Transplant 1995;16:565-570.
15. Paganini H, Staffolani V, Zubizarreta P, et al. Viridans streptococci bacteraemia in children with fever and neutropenia: A case-control study of predisposing factors. Eur J Cancer 2003;39:1284-1289.
16. Abrahamsson J, Forestier E, Heldrup J, et al. Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. J Clin Oncol 2011;29:310-315.
17. Hasle H, Abrahamsson J, Forestier E, et al. Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with aml: Results from NOPHO-AML 2004. Blood 2012;120:978-984.
18. Brunet AS, Ploton C, Galambrun C, et al. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia. Pediatr Blood Cancer 2006;47:765-772.
19. Frommell GT, Todd JK. Polymicrobial bacteremia in pediatric patients. Am J Dis Child 1984;138:266-269.
20. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8.
21. Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: A review. Am J Med 1994;97:256-264.
22. Reilly AF, Lange BJ. Infections with viridans group streptococci in children with cancer. Pediatr Blood Cancer 2007;49:774-780.
23. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors. Clin Infect Dis 1992;14:1201-1207.
24. Hammond SP, Baden LR. Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia. Curr Hematol Malig Rep 2007;2:97-103.
25. Bergmann OJ, Ellermann-Eriksen S, Mogensen SC, et al. Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: Randomised, double blind, placebo controlled trial. BMJ 1995;310:1169-1172.
26. Ringden O, Heimdahl A, Lonnqvist B, et al. Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir. Lancet 1984;1:744.
27. Kurt B, Flynn P, Shenep JL, et al. Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer 2008;113:376-382.